Clinical trial
Study of the Safety and Effectiveness of the OculusGen Collagen Matrix Implant as an Aid in Glaucoma Surgery
NCT00406822 is registered in ClinicalTrials.gov with Pro Top & Mediking Company Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Safety and Effectiveness of the OculusGen Collagen Matrix Implant as an Aid in Glaucoma Surgery
- Lead sponsor
- Pro Top & Mediking Company Limited
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 31, 2006
- Completion date
- Not reported
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.